Topic

Florida

A collection of 504 issues

Myths vs. Facts: Getting Keytruda (Pembrolizumab) Covered by Cigna in Florida

Answer Box: Keytruda Coverage Essentials for Cigna Members in Florida Keytruda (pembrolizumab) requires prior authorization from Cigna, with approval based on FDA-approved indications, required biomarker testing (PD-L1, MSI-H, or TMB-H), and proper documentation of diagnosis/staging. Submit PA forms via CoverMyMeds or ExpressPAth for 5-day standard processing. If denied, you

How to Get Ozempic and Mounjaro Covered by Aetna CVS Health in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Fastest Path to Approval To get Ozempic or Mounjaro covered by Aetna CVS Health in Florida: Your doctor must submit a prior authorization (PA) request through Aetna's provider portal or by fax, documenting your Type 2 diabetes diagnosis, A1C levels, and failed trials with metformin or

Cigna's Coverage Criteria for Trikafta in Florida: What Counts as "Medically Necessary"?

Answer Box: Getting Trikafta Covered by Cigna in Florida Cigna requires prior authorization (PA) for Trikafta in Florida with documented cystic fibrosis diagnosis (ICD-10 E84.0), confirmed CFTR genotype (F508del or responsive mutations), and prescription from a CF specialist. Standard PA review takes 5 business days; expedited review available for

How to Get Increlex (Mecasermin) Covered by Aetna CVS Health in Florida: Complete Prior Authorization Guide

Quick Answer: Getting Increlex (Mecasermin) Covered by Aetna CVS Health in Florida Aetna CVS Health covers Increlex (mecasermin) for Florida children with severe primary IGF-1 deficiency when specific criteria are met. Your pediatric endocrinologist must submit prior authorization showing height ≥3 standard deviations below normal, IGF-1 levels ≥3 SD below

Renewing Naglazyme (Galsulfase) Approval with Aetna (CVS Health) in Florida: Complete Guide to Prior Authorization Renewal

Answer Box: Renewing Naglazyme (Galsulfase) Coverage with Aetna (CVS Health) in Florida Aetna requires annual prior authorization renewal for Naglazyme (galsulfase) with documented clinical response to therapy. Start your renewal 60-90 days before expiration to avoid treatment gaps. Key requirements include: (1) confirmation of clinically positive response showing improvement, stabilization,

Myths vs. Facts: Getting Eylea and Lucentis Covered by Humana in Florida (Complete Appeals Guide)

Answer Box: Getting Eylea/Lucentis Covered by Humana in Florida Myth: A doctor's prescription guarantees Humana will cover Eylea or Lucentis. Fact: Humana requires prior authorization with specific documentation including OCT imaging, visual acuity data, and often step therapy with bevacizumab first. In Florida, you have 65 days

How Long Does It Take to Get Hetlioz (tasimelteon) Approved by Aetna (CVS Health) in Florida? Complete Timeline Guide

Answer Box: Hetlioz (Tasimelteon) Approval Timeline with Aetna in Florida Standard timeline: 30-45 days maximum for Aetna (CVS Health) prior authorization decisions in Florida, with urgent cases decided within 72 hours. Most complete submissions are processed within 7-10 days. Key requirements: diagnosis by sleep specialist, documented melatonin failure (≥6 months)

Blue Cross Blue Shield Florida's Coverage Criteria for Opfolda (miglustat): What Counts as "Medically Necessary"?

Answer Box: Getting Opfolda (miglustat) Approved by Blue Cross Blue Shield in Florida Quick Answer: Opfolda requires prior authorization from Blue Cross Blue Shield Florida and must be prescribed with Pombiliti for late-onset Pompe disease patients ≥40kg who aren't improving on current enzyme replacement therapy. Fastest path: Have

How to Get Oxlumo (lumasiran) Covered by UnitedHealthcare in Florida: Complete Guide with Forms, Appeals, and Timelines

Answer Box: UnitedHealthcare requires prior authorization for Oxlumo (lumasiran) in Florida, with approval typically requiring: (1) confirmed PH1 diagnosis via AGXT genetic testing, (2) specialist prescriber (nephrologist/geneticist), (3) elevated urinary oxalate levels, and (4) eGFR ≥30 mL/min/1.73 m². First step today: Have your nephrologist or geneticist

If Strimvelis (ADA-SCID Gene Therapy) Isn't Approved by Blue Cross Blue Shield in Florida: Alternative Treatments & Exception Paths

Answer Box: Your Options When Strimvelis Gene Therapy Is Denied If Blue Cross Blue Shield (BCBS) in Florida denies Strimvelis gene therapy for ADA-SCID, you have three main paths: PEG-ADA enzyme replacement therapy as a bridge treatment, allogeneic stem cell transplant if a donor is available, or formulary exception appeal